Verbatim response from ChatGPT
Short answer
- Topical minoxidil (foam/solution) is the usual first‑line treatment because it’s FDA‑approved for hair loss and has a lower risk of systemic side effects.
- Low‑dose oral minoxidil (LDOM) can be equal to or more effective for some people — especially those who don’t respond to or can’t tolerate topical — but it’s off‑label and has higher systemic risk, so it requires medical supervision.
How they work (brief)
- Both appear to lengthen the anagen (growth) phase and increase blood flow to hair follicles; the exact mechanism isn’t fully known.
- Topical delivers the drug locally to the scalp with minimal systemic absorption. Oral gives whole‑body exposure.
Efficacy
- Topical 5% (men) or 2–5% (women) usually produces visible improvement by 3–6 months, maximal at ~12 months.
- Low‑dose oral (typical regimens used by hair specialists range from about 0.25–5 mg nightly) often produces similar or better hair counts in published series and clinical practice, especially in people who fail topical therapy.
- There isn’t a single large head‑to‑head definitive trial, but multiple small trials and clinical experience support oral minoxidil as an effective option.
Safety and monitoring
- Topical: main issues are scalp irritation, contact dermatitis, and local unwanted hair (facial hair from runoff). Systemic absorption and blood‑pressure effects are uncommon.
- Oral: can cause fluid retention/edema, increased heart rate, palpitations, low blood pressure, and generalized hypertrichosis (excess body/facial hair). Rarely can exacerbate cardiac disease. Because of these risks, doctors usually check baseline blood pressure and may monitor weight, heart rate, and symptoms; people on antihypertensives or with heart disease need careful evaluation.
- Pregnancy/breastfeeding: avoid oral minoxidil and discuss topical use with your doctor — topical is generally used with caution or avoided in pregnancy.
Practical recommendation
- Start with topical minoxidil (5% foam or solution for men; many women use 5% foam or 2% solution depending on tolerance and provider guidance). It’s safe, widely available, and effective for many.
- If you don’t respond, can’t tolerate topical (scalp irritation), or prefer an oral option, talk to a dermatologist or your primary care physician about low‑dose oral minoxidil. They’ll review cardiac history, check blood pressure, and arrange follow‑up.
- For men with male pattern hair loss, consider combining topical/oral minoxidil with finasteride (oral) for better results — discuss risks/benefits with your clinician.
Brands and services (examples)
- Topical: Rogaine (branded minoxidil foam/solution), or lower‑cost generics such as Kirkland Signature (Costco) or store brands — these contain the same active ingredient.
- Oral: Loniten is the prescription oral minoxidil formulation used for hypertension (and used off‑label for hair loss). Many clinicians use low doses of Loniten or obtain low‑dose preparations from compounding pharmacies to titrate doses smaller than standard antihypertensive tablets.
- If you’re unsure where to start, book a visit with a board‑certified dermatologist who treats hair loss; many offer telederm visits and can manage dosing and monitoring.
Bottom line Topical minoxidil is the safer, standard first choice. Low‑dose oral minoxidil can work as well or better for some people but carries more systemic risks and requires physician supervision. Discuss your medical history and goals with a dermatologist to choose the best option.